Impact of right ventricular lead position on cardiac resynchronization therapy efficacy

Pei Bao,Kangyu Chen,Fei Yu,Hao Su,Ji Yan,Jian Xu,Chunsheng An,Dongmei Yang
DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2017.05.009
2017-01-01
Abstract:Objective To investigate if right ventricular middle septum(RVMS)could further improve the treatment effects compared with right ventricular apex(RVA) in the patients receiving cardiac resynchroni-zation therapy(CRT). Methods A total of 386 CRT-P/D patients were enrolled in this study between January 2001 and June 2015.The enrolled patients were divided into two groups based on the RV lead location,RVMS 155 and RVA 231.At 6-month follow-up the Echocardiographic characteristics were compared,including left ventricular end-diastolic volume(LVEDV),left ventricular end-systolic volume(LVESV),left ventricular ejec-tion fraction(LVEF),systolic dyssynchrony index(SDI),QRS duration,and clinical outcomes were compared too.The time to first HF hospitalization or death were recorded in 12 moths. Results After 6-month RVMS group was compared with RVA group,there were no significant differences in reduction of LVESV[(19.43+12.19) ml vs.(20.19+12.88) ml,P=0.56]、LVESV[(35.9+21.5) ml vs.(36.6+22.9) ml,P=0.77], or improvement of LVEF(8.94%+5.42% vs. 8.75%+5.51%,P=0.74).The reductiong of LVESV>15%was similar in both groups(RVMS 60% vs. RVA 62%,P=0.58),the NYHA improved in both group(1.01+0.37 vs. 1.10+0.36,P=0.42),but the difference was not statistically significant.The first HF hospitaliza-tion or death was 16.8% in RVMS group and 19.5% in RVA group)with no significantly difference between the two groups in 12 moths(P=0.50). Conclusions Compared with RVA,RVMS could not improve cardi-ac systolic synchrony、clinical symptoms and prognosis furthermore.
What problem does this paper attempt to address?